Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Cognitive Impairment in Major Depressive Disorder : Clinical Relevance, Biological Substrates, and Treatment Opportunities, Hardback Book

Cognitive Impairment in Major Depressive Disorder : Clinical Relevance, Biological Substrates, and Treatment Opportunities Hardback

Edited by Roger S. (University of Toronto) McIntyre

Hardback

Description

Major depressive disorder (MDD) is the leading cause of disability globally in both developed and developing nations.

The staggering economic costs attributable to MDD are largely a consequence of impairment in role function.

Evidence indicates that disturbance in the domain of cognitive function in individuals with MDD is the principal determinant of health outcome.

This is the first book to comprehensively explore the domain of cognition in MDD.

The literature describing cognitive dysfunction is reviewed with particular focus on clinical determinants, pathophysiology and causative factors.

The patient subpopulations most susceptible are defined.

A summary of contemporary assessment tools for research and clinical purposes is provided.

Multimodality treatments and prevention strategies are described.

This book is an invaluable resource for psychiatrists, neuropsychologists and other members of the mental health team, as well as for policy makers, vocation rehabilitation experts, disability providers and other stakeholders interested in improving health outcomes in MDD.

Information

Save 0%

£97.99

£97.25

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information